PHASES Score for Prediction of Intracranial Aneurysm Growth

BACKGROUND AND PURPOSE—Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also pr...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 46; no. 5; pp. 1221 - 1226
Main Authors Backes, Daan, Vergouwen, Mervyn D.I, Tiel Groenestege, Andreas T, Bor, A. Stijntje E, Velthuis, Birgitta K, Greving, Jacoba P, Algra, Ale, Wermer, Marieke J.H, van Walderveen, Marianne A.A, terBrugge, Karel G, Agid, Ronit, Rinkel, Gabriel J.E
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND AND PURPOSE—Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth. METHODS—In a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles. RESULTS—We included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5–10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22–1.43). With the lowest quartile of the PHASES score (0–1) as reference, hazard ratios were for the second (PHASES 2–3) 1.07 (95% CI, 0.49–2.32), the third (PHASES 4) 2.29 (95% CI, 1.05–4.95), and the fourth quartile (PHASES 5–14) 2.85 (95% CI, 1.43–5.67). CONCLUSIONS—Higher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture.
AbstractList BACKGROUND AND PURPOSEGrowth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth.METHODSIn a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles.RESULTSWe included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5-10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22-1.43). With the lowest quartile of the PHASES score (0-1) as reference, hazard ratios were for the second (PHASES 2-3) 1.07 (95% CI, 0.49-2.32), the third (PHASES 4) 2.29 (95% CI, 1.05-4.95), and the fourth quartile (PHASES 5-14) 2.85 (95% CI, 1.43-5.67).CONCLUSIONSHigher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture.
Background and Purpose— Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth. Methods— In a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles. Results— We included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5–10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22–1.43). With the lowest quartile of the PHASES score (0–1) as reference, hazard ratios were for the second (PHASES 2–3) 1.07 (95% CI, 0.49–2.32), the third (PHASES 4) 2.29 (95% CI, 1.05–4.95), and the fourth quartile (PHASES 5–14) 2.85 (95% CI, 1.43–5.67). Conclusions— Higher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture.
Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth. In a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles. We included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5-10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22-1.43). With the lowest quartile of the PHASES score (0-1) as reference, hazard ratios were for the second (PHASES 2-3) 1.07 (95% CI, 0.49-2.32), the third (PHASES 4) 2.29 (95% CI, 1.05-4.95), and the fourth quartile (PHASES 5-14) 2.85 (95% CI, 1.43-5.67). Higher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture.
BACKGROUND AND PURPOSE—Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated whether PHASES, a score providing absolute risks of aneurysm rupture based on 6 easily retrievable risk factors, also predicts aneurysm growth. METHODS—In a multicenter cohort of patients with unruptured intracranial aneurysms and follow-up imaging with computed tomography angiography or magnetic resonance angiography, we performed univariable and multivariable Cox regression analyses for the predictors of the PHASES score at baseline, with aneurysm growth as outcome. We calculated hazard ratios and corresponding 95% confidence intervals (CI), with the PHASES score as continuous variable and after division into quartiles. RESULTS—We included 557 patients with 734 unruptured aneurysms. Eighty-nine (12%) aneurysms in 87 patients showed growth during a median follow-up of 2.7 patient-years (range 0.5–10.8). Per point increase in PHASES score, hazard ratio for aneurysm growth was 1.32 (95% CI, 1.22–1.43). With the lowest quartile of the PHASES score (0–1) as reference, hazard ratios were for the second (PHASES 2–3) 1.07 (95% CI, 0.49–2.32), the third (PHASES 4) 2.29 (95% CI, 1.05–4.95), and the fourth quartile (PHASES 5–14) 2.85 (95% CI, 1.43–5.67). CONCLUSIONS—Higher PHASES scores were associated with an increased risk of aneurysm growth. Because higher PHASES scores also predict aneurysm rupture, our findings suggest that aneurysm growth can be used as surrogate outcome measure of aneurysm rupture in follow-up studies on risk prediction or interventions aimed to reduce the risk of rupture.
Author Tiel Groenestege, Andreas T
Backes, Daan
Greving, Jacoba P
van Walderveen, Marianne A.A
Velthuis, Birgitta K
Rinkel, Gabriel J.E
Vergouwen, Mervyn D.I
Bor, A. Stijntje E
Algra, Ale
Agid, Ronit
Wermer, Marieke J.H
terBrugge, Karel G
AuthorAffiliation From the Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus (D.B., M.D.I.V., A.T.T.G., A.S.E.B., A.A., G.J.E.R.), Department of Radiology (B.K.V.), and Julius Center for Health Sciences and Primary Care (J.P.G., A.A.), University Medical Center Utrecht, Utrecht, the Netherlands; Departments of Neurology (M.J.H.W.) and Radiology (M.A.A.v.W.), Leiden University Medical Center, Leiden, the Netherlands; and Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, Toronto, Canada (K.G.t.B., R.A.)
AuthorAffiliation_xml – name: From the Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus (D.B., M.D.I.V., A.T.T.G., A.S.E.B., A.A., G.J.E.R.), Department of Radiology (B.K.V.), and Julius Center for Health Sciences and Primary Care (J.P.G., A.A.), University Medical Center Utrecht, Utrecht, the Netherlands; Departments of Neurology (M.J.H.W.) and Radiology (M.A.A.v.W.), Leiden University Medical Center, Leiden, the Netherlands; and Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, Toronto, Canada (K.G.t.B., R.A.)
Author_xml – sequence: 1
  givenname: Daan
  surname: Backes
  fullname: Backes, Daan
  organization: From the Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus (D.B., M.D.I.V., A.T.T.G., A.S.E.B., A.A., G.J.E.R.), Department of Radiology (B.K.V.), and Julius Center for Health Sciences and Primary Care (J.P.G., A.A.), University Medical Center Utrecht, Utrecht, the Netherlands; Departments of Neurology (M.J.H.W.) and Radiology (M.A.A.v.W.), Leiden University Medical Center, Leiden, the Netherlands; and Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, Toronto, Canada (K.G.t.B., R.A.)
– sequence: 2
  givenname: Mervyn
  surname: Vergouwen
  middlename: D.I
  fullname: Vergouwen, Mervyn D.I
– sequence: 3
  givenname: Andreas
  surname: Tiel Groenestege
  middlename: T
  fullname: Tiel Groenestege, Andreas T
– sequence: 4
  givenname: A. Stijntje
  surname: Bor
  middlename: E
  fullname: Bor, A. Stijntje E
– sequence: 5
  givenname: Birgitta
  surname: Velthuis
  middlename: K
  fullname: Velthuis, Birgitta K
– sequence: 6
  givenname: Jacoba
  surname: Greving
  middlename: P
  fullname: Greving, Jacoba P
– sequence: 7
  givenname: Ale
  surname: Algra
  fullname: Algra, Ale
– sequence: 8
  givenname: Marieke
  surname: Wermer
  middlename: J.H
  fullname: Wermer, Marieke J.H
– sequence: 9
  givenname: Marianne
  surname: van Walderveen
  middlename: A.A
  fullname: van Walderveen, Marianne A.A
– sequence: 10
  givenname: Karel
  surname: terBrugge
  middlename: G
  fullname: terBrugge, Karel G
– sequence: 11
  givenname: Ronit
  surname: Agid
  fullname: Agid, Ronit
– sequence: 12
  givenname: Gabriel
  surname: Rinkel
  middlename: J.E
  fullname: Rinkel, Gabriel J.E
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25757900$$D View this record in MEDLINE/PubMed
BookMark eNp9kF1LwzAUhoNM3Kb-A5FeetOZpOlH8KqMuQ0HG3ZelyQ9YdWumUnL2L-30rlLrw4Hnvc9h2eMBrWpAaEHgieEROQ5276v32bpIu1WNsE4ITy5QiMSUuaziCYDNMI44D5lnA_R2LlPjDENkvAGDWkYhzHHeIReNos0m2VepowFTxvrbSwUpWpKU3tGe8u6sUJZUZei8tIaWntye29uzbHZ3aFrLSoH9-d5iz5eZ9vpwl-t58tpuvJV2P3ky0QEEXDNmVKxpFwVCgoOgZIcMCmYpMBiTaJAKyl5rITEEAWc00hLyhQLbtFT33uw5rsF1-T70imoKlGDaV1OojgKOWUx7VDWo8oa5yzo_GDLvbCnnOD8V1t-0datLO-1dbHH84VW7qG4hP48dUDSA0dTNWDdV9UeweY7EFWz-7_7ByV0fM4
CitedBy_id crossref_primary_10_1007_s00330_023_10388_7
crossref_primary_10_1016_j_wneu_2023_03_138
crossref_primary_10_1161_STROKEAHA_115_012162
crossref_primary_10_1007_s00701_024_05901_w
crossref_primary_10_3389_fneur_2021_590751
crossref_primary_10_1007_s00062_017_0640_6
crossref_primary_10_3171_2021_6_JNS204155
crossref_primary_10_1186_s40001_024_01888_3
crossref_primary_10_1016_j_jocn_2023_07_025
crossref_primary_10_3389_fneur_2017_00451
crossref_primary_10_3340_jkns_2020_0144
crossref_primary_10_1177_0300060516671600
crossref_primary_10_1093_neuros_nyz311
crossref_primary_10_3171_2019_4_FOCUS1987
crossref_primary_10_16977_cbfm_30_1_35
crossref_primary_10_1016_j_nec_2017_02_006
crossref_primary_10_1021_acs_chemmater_0c00208
crossref_primary_10_1038_nrneurol_2015_146
crossref_primary_10_3389_fneur_2022_818335
crossref_primary_10_1016_j_inat_2020_100920
crossref_primary_10_3389_fphys_2021_644349
crossref_primary_10_3171_2017_3_JNS162984
crossref_primary_10_1080_02688697_2021_1995587
crossref_primary_10_1016_j_clineuro_2021_106877
crossref_primary_10_1371_journal_pone_0264616
crossref_primary_10_3174_ajnr_A8058
crossref_primary_10_3174_ajnr_A5341
crossref_primary_10_1097_MD_0000000000028696
crossref_primary_10_1161_SVIN_123_000625
crossref_primary_10_3174_ajnr_A6080
crossref_primary_10_1136_neurintsurg_2020_016811
crossref_primary_10_1159_000517421
crossref_primary_10_3171_2018_11_JNS181814
crossref_primary_10_1007_s10143_024_02408_x
crossref_primary_10_1136_neurintsurg_2020_016654
crossref_primary_10_1016_j_medengphy_2019_09_010
crossref_primary_10_1177_1756286420987939
crossref_primary_10_1016_j_wneu_2017_11_093
crossref_primary_10_1097_01_CNE_0000482104_64218_a4
crossref_primary_10_1007_s11886_016_0763_4
crossref_primary_10_1161_STROKEAHA_117_017391
crossref_primary_10_1177_1747493018790033
crossref_primary_10_1177_15910199231201520
crossref_primary_10_1016_j_ijsu_2019_07_023
crossref_primary_10_1016_j_wneu_2019_07_163
crossref_primary_10_1007_s10143_020_01407_y
crossref_primary_10_7887_jcns_29_101
crossref_primary_10_1016_j_cmpb_2022_107237
crossref_primary_10_1161_STROKEAHA_118_021030
crossref_primary_10_1016_j_neurol_2017_05_004
crossref_primary_10_1136_jnis_2022_019905
crossref_primary_10_1016_j_jstrokecerebrovasdis_2023_107052
crossref_primary_10_1016_j_wneu_2020_12_041
crossref_primary_10_1212_WNL_0000000000010997
crossref_primary_10_3171_2018_5_JNS18322
crossref_primary_10_1055_a_2291_5230
crossref_primary_10_3174_ajnr_A7865
crossref_primary_10_1055_a_1532_9244
crossref_primary_10_1007_s12975_017_0560_4
crossref_primary_10_1007_s00701_017_3239_4
crossref_primary_10_1055_s_0043_1763528
crossref_primary_10_3174_ajnr_A7186
crossref_primary_10_1038_nrneurol_2016_150
crossref_primary_10_3389_fcvm_2022_900647
crossref_primary_10_7326_M17_0246
crossref_primary_10_1177_1971400916638357
crossref_primary_10_1016_j_wneu_2019_09_103
crossref_primary_10_1007_s11548_022_02818_6
crossref_primary_10_1007_s13167_023_00315_7
crossref_primary_10_3389_fneur_2021_619864
crossref_primary_10_1016_j_wneu_2019_12_127
crossref_primary_10_1177_1358863X18754693
crossref_primary_10_1016_j_compbiomed_2022_105740
crossref_primary_10_1134_S0021894422020080
crossref_primary_10_1186_s12938_019_0657_y
crossref_primary_10_1136_neurintsurg_2016_012295
crossref_primary_10_1016_j_inat_2018_02_003
crossref_primary_10_1016_j_clineuro_2021_106949
crossref_primary_10_1136_jnis_2023_021227
crossref_primary_10_1016_j_jocn_2018_08_006
crossref_primary_10_1007_s12975_024_01261_w
crossref_primary_10_23736_S0390_5616_21_05481_3
crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_105763
crossref_primary_10_1136_neurintsurg_2016_012327
crossref_primary_10_1016_j_wneu_2017_01_097
crossref_primary_10_1161_JAHA_120_018626
crossref_primary_10_1002_jmri_28234
crossref_primary_10_1016_j_wneu_2023_10_128
crossref_primary_10_3171_2018_4_JNS173221
crossref_primary_10_5469_neuroint_2018_01011
crossref_primary_10_1080_14737175_2016_1199958
crossref_primary_10_1007_s10143_020_01352_w
crossref_primary_10_1007_s11517_024_03136_6
crossref_primary_10_1227_NEU_0000000000000835
crossref_primary_10_1016_j_cmpb_2023_107963
crossref_primary_10_7461_jcen_2023_E2022_10_011
crossref_primary_10_1016_j_neuroimage_2021_118216
crossref_primary_10_1016_j_wneu_2019_03_094
crossref_primary_10_3349_ymj_2021_62_11_1052
crossref_primary_10_1212_WNL_0000000000003874
crossref_primary_10_1161_STROKEAHA_120_029967
crossref_primary_10_1109_ACCESS_2018_2799307
crossref_primary_10_34067_KID_0000000000000092
crossref_primary_10_1016_j_wneu_2018_03_003
crossref_primary_10_1093_neuros_nyy161
crossref_primary_10_3174_ajnr_A7418
crossref_primary_10_3171_2019_6_JNS19704
crossref_primary_10_17802_2306_1278_2023_12_1_172_180
crossref_primary_10_1136_practneurol_2020_002521
crossref_primary_10_7887_jcns_31_74
crossref_primary_10_1016_j_acra_2021_06_013
crossref_primary_10_1016_j_jocn_2018_04_014
crossref_primary_10_1007_s00062_019_00809_w
crossref_primary_10_1136_jnis_2023_021113
crossref_primary_10_1212_WNL_0000000000003865
Cites_doi 10.1227/NEU.0b013e3182354d68
10.1056/NEJMoa1113260
10.3171/jns.2004.101.6.0908
10.3171/2012.11.JNS121210
10.1161/STROKEAHA.113.001838
10.1161/STROKEAHA.113.001138
10.1097/00006123-200112000-00006
10.1148/radiol.13121188
10.1097/00006123-200103000-00007
10.1016/0303-8467(93)90125-Z
10.1148/radiol.10091982
10.1016/S1474-4422(13)70263-1
10.1227/01.NEU.0000217366.02567.D2
10.1161/STROKEAHA.113.004421
10.3171/jns.2003.99.3.0447
10.1161/STROKEAHA.114.005963
10.3171/2012.7.JNS111766
10.1227/01.NEU.0000124482.03676.8B
10.1136/neurintsurg-2013-010944
10.3171/2013.3.JNS121469
10.1161/01.STR.0000199077.06390.35
10.1136/jnnp.2008.169573
10.1136/jnnp-2011-302068
10.1227/NEU.0b013e31820edbd3
10.1161/01.STR.32.2.485
10.1007/s00234-010-0804-4
10.1161/STROKEAHA.109.566018
10.3171/jns.2002.96.1.0064
10.1161/STROKEAHA.108.519165
10.3171/JNS/2008/109/8/0176
10.3171/jns.2002.97.5.1023
10.1161/STROKEAHA.109.574244
10.1007/s00701-012-1566-z
10.1007/s00234-004-1324-x
10.1016/j.jclinepi.2009.12.008
10.1227/01.NEU.0000316847.64140.81
10.1016/S1474-4422(11)70109-0
10.1136/bmj.b604
ContentType Journal Article
Copyright 2015 American Heart Association, Inc.
Copyright_xml – notice: 2015 American Heart Association, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1161/STROKEAHA.114.008198
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4628
EndPage 1226
ExternalDocumentID 10_1161_STROKEAHA_114_008198
25757900
10.1161/STROKEAHA.114.008198
Genre Multicenter Study
Journal Article
GroupedDBID -
.XZ
.Z2
01R
08R
0R
123
1AW
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
55
5RE
5VS
71W
77Y
7O
7O~
AAAXR
AAMOA
AAMTA
AAPBV
AAQQT
AARTV
AAXQO
AAYEP
AAYJJ
ABBUW
ABFLS
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACGOD
ACWDW
ACWRI
ACXNZ
ADACO
ADBBV
ADFPA
ADNKB
AE3
AENEX
AFFNX
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
AJNYG
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BAWUL
BOYCO
BQLVK
C45
CS3
DIK
DU5
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FL-
FW0
GJ
GX1
H0
H0~
H13
HZ
IKYAY
IN
IN~
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
OGROG
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWW
OWY
OXXIT
P-K
P2P
PQEST
PQQKQ
R58
RAH
RHF
RIG
RLZ
RSW
S4R
S4S
TWZ
V2I
WH7
WOQ
WOW
X3V
X3W
X7M
XZ
YCJ
YHZ
YQJ
Z2
ZA5
ZGI
---
.3C
.55
.GJ
0R~
6PF
A9M
AAAAV
AAGIX
AAHPQ
AAIQE
AAJCS
AAQKA
AASCR
AASOK
AAUEB
ABASU
ABDIG
ABJNI
ABQRW
ABVCZ
ACCJW
ACILI
ACLDA
ACXJB
ADGGA
ADHPY
AE6
AEBDS
AEETU
AFDTB
AFEXH
AFSOK
AGINI
AHOMT
AHQNM
AHRYX
AINUH
AJNWD
AJZMW
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
AYCSE
BCGUY
BS7
CGR
CUY
CVF
DIWNM
ECM
EEVPB
EIF
ERAAH
FCALG
GNXGY
GQDEL
HLJTE
HZ~
IKREB
IPNFZ
M18
N4W
NPM
ODMTH
OHYEH
OJAPA
OWBYB
OWU
OWV
OWX
OWZ
T8P
TEORI
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
YYP
ZB8
ZZMQN
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c5198-b8a36e9f94cc7b29cdced9e3cb9e01d4b2e47f163fcbb97cab0e639926fb24c43
ISSN 0039-2499
IngestDate Sat Oct 26 00:28:44 EDT 2024
Fri Aug 23 01:48:50 EDT 2024
Tue Oct 15 23:55:15 EDT 2024
Thu Aug 13 19:50:28 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords PHASES
follow-up
unruptured aneurysm
growth
imaging
Language English
License 2015 American Heart Association, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5198-b8a36e9f94cc7b29cdced9e3cb9e01d4b2e47f163fcbb97cab0e639926fb24c43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.114.008198
PMID 25757900
PQID 1676592472
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1676592472
crossref_primary_10_1161_STROKEAHA_114_008198
pubmed_primary_25757900
wolterskluwer_health_10_1161_STROKEAHA_114_008198
ProviderPackageCode OVOZU
L-C
C45
7O~
AARTV
ADFPA
OLH
ASCII
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
OGROG
OVLEI
AJIOK
OPUJH
V2I
.XZ
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
ACEWG
OB3
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OUVQU
ORVUJ
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
AAMTA
AAAXR
E.X
OWW
OCUKA
OWY
01R
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
FW0
PublicationCentury 2000
PublicationDate 2015-May
PublicationDateYYYYMMDD 2015-05-01
PublicationDate_xml – month: 05
  year: 2015
  text: 2015-May
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Stroke (1970)
PublicationTitleAlternate Stroke
PublicationYear 2015
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_3_2
e_1_3_3_21_2
References_xml – ident: e_1_3_3_23_2
  doi: 10.1227/NEU.0b013e3182354d68
– ident: e_1_3_3_34_2
  doi: 10.1056/NEJMoa1113260
– ident: e_1_3_3_13_2
  doi: 10.3171/jns.2004.101.6.0908
– ident: e_1_3_3_36_2
  doi: 10.3171/2012.11.JNS121210
– ident: e_1_3_3_9_2
  doi: 10.1161/STROKEAHA.113.001838
– ident: e_1_3_3_31_2
  doi: 10.1161/STROKEAHA.113.001138
– ident: e_1_3_3_7_2
  doi: 10.1097/00006123-200112000-00006
– ident: e_1_3_3_17_2
  doi: 10.1148/radiol.13121188
– ident: e_1_3_3_25_2
  doi: 10.1097/00006123-200103000-00007
– ident: e_1_3_3_33_2
  doi: 10.1016/0303-8467(93)90125-Z
– ident: e_1_3_3_4_2
  doi: 10.1148/radiol.10091982
– ident: e_1_3_3_8_2
  doi: 10.1016/S1474-4422(13)70263-1
– ident: e_1_3_3_12_2
  doi: 10.1227/01.NEU.0000217366.02567.D2
– ident: e_1_3_3_37_2
  doi: 10.1161/STROKEAHA.113.004421
– ident: e_1_3_3_24_2
  doi: 10.3171/jns.2003.99.3.0447
– ident: e_1_3_3_22_2
  doi: 10.1161/STROKEAHA.114.005963
– ident: e_1_3_3_26_2
  doi: 10.3171/2012.7.JNS111766
– ident: e_1_3_3_27_2
  doi: 10.1227/01.NEU.0000124482.03676.8B
– ident: e_1_3_3_18_2
  doi: 10.1136/neurintsurg-2013-010944
– ident: e_1_3_3_16_2
  doi: 10.3171/2013.3.JNS121469
– ident: e_1_3_3_15_2
  doi: 10.1161/01.STR.0000199077.06390.35
– ident: e_1_3_3_28_2
  doi: 10.1136/jnnp.2008.169573
– ident: e_1_3_3_5_2
  doi: 10.1136/jnnp-2011-302068
– ident: e_1_3_3_39_2
  doi: 10.1227/NEU.0b013e31820edbd3
– ident: e_1_3_3_21_2
  doi: 10.1161/01.STR.32.2.485
– ident: e_1_3_3_29_2
  doi: 10.1007/s00234-010-0804-4
– ident: e_1_3_3_3_2
  doi: 10.1161/STROKEAHA.109.566018
– ident: e_1_3_3_6_2
  doi: 10.3171/jns.2002.96.1.0064
– ident: e_1_3_3_11_2
  doi: 10.1161/STROKEAHA.108.519165
– ident: e_1_3_3_38_2
  doi: 10.3171/JNS/2008/109/8/0176
– ident: e_1_3_3_14_2
  doi: 10.3171/jns.2002.97.5.1023
– ident: e_1_3_3_32_2
  doi: 10.1161/STROKEAHA.109.574244
– ident: e_1_3_3_10_2
  doi: 10.1007/s00701-012-1566-z
– ident: e_1_3_3_35_2
  doi: 10.1007/s00234-004-1324-x
– ident: e_1_3_3_20_2
  doi: 10.1016/j.jclinepi.2009.12.008
– ident: e_1_3_3_30_2
  doi: 10.1227/01.NEU.0000316847.64140.81
– ident: e_1_3_3_2_2
  doi: 10.1016/S1474-4422(11)70109-0
– ident: e_1_3_3_19_2
  doi: 10.1136/bmj.b604
SSID ssj0002385
Score 2.5567436
Snippet BACKGROUND AND PURPOSE—Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm...
Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm rupture. We investigated...
Background and Purpose— Growth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm...
BACKGROUND AND PURPOSEGrowth of an intracranial aneurysm occurs in around 10% of patients at 2-year follow-up imaging and may be associated with aneurysm...
SourceID proquest
crossref
pubmed
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1221
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Aneurysm, Ruptured - pathology
Cerebral Angiography
Cohort Studies
Female
Follow-Up Studies
Humans
Intracranial Aneurysm - pathology
Male
Middle Aged
Predictive Value of Tests
Prognosis
Prospective Studies
Risk Assessment
Survival Analysis
Treatment Outcome
Young Adult
Title PHASES Score for Prediction of Intracranial Aneurysm Growth
URI https://www.ncbi.nlm.nih.gov/pubmed/25757900
https://search.proquest.com/docview/1676592472
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBATQtwpNwWJtyohcVw7EU8ZFLVMhYl1aG-R7TjQbSQoTVWNX8DP5jjObVBNjJeojaqT1Of4O5_PxUboVRL6giZYbz7IYIEyDqQdUMptFQB_DpQUUuiA_vwjnR6RD8fj48HgV69qaV0KR_7c2lfyP1qFe6BX3SV7Bc22QuEGfAb9whU0DNd_0vHBNAI4hPmZF2bv7oNC510aEjjTgVsJzkhHxSO9c-X56ruONm3Kb31SelgW-WnFNb2Qub3YwB6HOW54Nu-s6IsqvubrjcGrOWDNeTZ658ycNgiwVGf6KRpFS2WObq_qJvlqtGh_tWfiBJEDfHd5kpUnajRx-jEIb9xV_DW46us8jTnqyFE1lGJi687XPtbW4cZlP5tdAaeHTaN07YThK90O8FQD_OHi86f9STSN9FbHTkVrgs6hNUn8P_xcW31YrXuoF7dSdGt2bKRcQ9cxQFaV8J_ttz4diI05C6P-n3UTJkh5ve1dLpKcv1Yuu-jWJtfFEKvTqheix2gWd9DteiliRcau7qKByu6hG_O62OI-emPMy6rMywLzsjrzsvLU6puX1ZiXZczrATp6P1m8ndr1WRu2BA4f2CLgPlVhGhIpmcChTKRKQuVLESrXS4jAirAUyHsqhQiZ5MJVmtximgpMJPEfop0sz9RjZDEtxxOBm7KUJCkDxskTl3AhMAd-S4fIbgYn_mG2VIkvU8kQvWxGMAbs0wktnql8vYo9ynRVAGF4iB6ZoW0lgisaw6PdIfIujHVs-osvfeKTK77hU3SzmxXP0E5ZrNVz4KqleFGZ0W_r5Ip8
link.rule.ids 315,783,787,27936,27937
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PHASES+Score+for+Prediction+of+Intracranial+Aneurysm+Growth&rft.jtitle=Stroke+%281970%29&rft.au=Backes%2C+Daan&rft.au=Vergouwen%2C+Mervyn+D.I.&rft.au=Tiel+Groenestege%2C+Andreas+T.&rft.au=Bor%2C+A.+Stijntje+E.&rft.date=2015-05-01&rft.issn=0039-2499&rft.eissn=1524-4628&rft.volume=46&rft.issue=5&rft.spage=1221&rft.epage=1226&rft_id=info:doi/10.1161%2FSTROKEAHA.114.008198&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_STROKEAHA_114_008198
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon